Explore every episode of the podcast Inside Scope

Welcome to episode four of our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, introduce the principles of Enhanced Recovery After Surgery (ERAS) and discuss how this evidence-based framework applies to the perioperative care of patients with inflammatory bowel disease (IBD). The conversation will explore the unique considerations for individuals with IBD undergoing surgery and highlight key strategies used to optimize surgical outcomes, including perioperative nutritional support, multidisciplinary care coordination, and patient-centered recovery planning. Listeners will gain practical insights into how ERAS principles can be integrated into clinical practice to support improved recovery, reduced complications, and better overall surgical outcomes for patients with IBD. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer.

Welcome to the final episode in our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, lead a discussion addressing common myths and misinformation surrounding diet and nutrition in inflammatory bowel disease (IBD). The conversation will explore frequently debated topics, including the role of gluten and dairy in IBD-related inflammation, the evidence behind food intolerance testing, and perceptions around organic versus conventional foods and their impact on health. Listeners will gain evidence-based clarity to help dispel nutrition myths, counsel patients with confidence, and support informed, balanced dietary decision-making in the management of IBD. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer.

Welcome to episode five of our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, lead a discussion focused on distinguishing the overlapping symptoms of irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) from inflammatory bowel disease (IBD). The conversation will examine how these conditions influence dietary choices and food-related quality of life (FRQoL), highlighting the clinical and psychosocial challenges patients often face. Listeners will gain practical insights into evidence-based approaches for both short-term and long-term management of IBS and SIBO, with an emphasis on individualized care strategies that minimize unnecessary dietary restriction while supporting symptom control and improved patient outcomes. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer.

Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. In episode two, “MASH: How to Treat and When to Refer,” Drs. Arun Sanyal and Mary Rinella take a look at the role that primary care physicians can play in the treatment of MASH, how can they treat and monitor these patients, and most importantly, when should a specialist be called in. Our experts will review current treatment guidelines and care pathways for MASH. They’ll discuss the role of PCPs in the multidisciplinary management of patients with MASH, including the referral of high-risk patients to specialists. Finally, they’ll share the management of underlying metabolic conditions, such as T2DM and obesity, in patients with MASH who are at low risk of fibrosis. This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting : https://suitehome.atpointofcare.com/library/2711.02/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. In episode one, “Recognizing a ‘Silent’ Disease,” Drs. Arun Sanyal and Mary Rinella will discuss MASH and the role that primary care physicians can play in its early detection and treatment. What are the challenges in diagnosing this often-silent disease? What do clinicians need to know to ensure that MASH doesn't fall off their radar? Listen as experts discuss challenges in MASLD/MASH diagnosis, including risk stratification of patients, and implications for diagnostic delays. Additionally, they’ll share strategies for incorporating noninvasive methods such as the FIB-4 score, NFS, APRI, and secondary assessments. Finally, the experts will emphasize the vital role PCPs play in MASH detection and management. This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting: https://suitehome.atpointofcare.com/library/2711.01/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Welcome to episode three of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Victoria Christianson, RD, to explore the critical topic of malnutrition in inflammatory bowel disease (IBD). The discussion will begin with practical approaches to screening and assessment, highlighting key red flags that clinicians should recognize in both outpatient and inpatient settings. The conversation will then delve into the dual challenges of sarcopenia and obesity, examining how variations in fat mass can influence the clinical course of IBD and impact patient outcomes. Listeners will gain insights into the nuances of managing nutrition for ambulatory versus hospitalized patients, including considerations for those with NPO status. The episode will provide actionable strategies for identifying at-risk patients, tailoring interventions, and collaborating with multidisciplinary teams to optimize nutritional care across the continuum of IBD management. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer

Welcome to episode one of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by guest Dr. Dale Lee to discuss the role of diet as a therapeutic approach for managing inflammatory bowel disease (IBD). The discussion will cover the distinction between symptoms and disease control, the use of enteral nutrition therapies, and the benefits of whole food-based diets. We will explore how exclusive enteral nutrition can be used to treat conditions like Crohn's disease and the importance of a close partnership with a dietitian. Our experts will also address the challenges and opportunities of using dietary therapy for IBD, including differences in nutritional therapy for adult versus pediatric patients and the future landscape of nutrition and IBD management. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer

Welcome to episode two of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Rotem Sigall Boneh, RD, to explore the essential aspects of integrating nutritional expertise into inflammatory bowel disease (IBD) management. This episode will cover how to effectively collaborate with a GI dietitian, emphasizing strategies for personalizing dietary interventions to ensure the right diet is matched to the right patient at the right time. Additionally, the group discusses the practicalities of referring patients to a dietitian and clarifies the differences between a nutritionist and a registered dietitian, helping health care providers make informed decisions about patient care. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer

There is some debate about when to recommend cessation of surveillance colonoscopy, especially in those who are 75-85 years old. In this episode of the AGA Perspectives series, Dr. Gyanprakash Ketwaroo and Dr. Moamen Gabr are joined by Dr. Mariam Naveed and Dr. Petr Protiva to discuss this common but tricky topic.

In this episode of the AGA Perspective series, Dr. Gyanprakash Ketwaroo hosts a discussion on the best practices for removing large or complex colon polyps. Joined by Drs. Jeffrey Mosko and Moamen Gabr, the conversation explores the evolution of endoscopic techniques, the importance of careful polyp selection, and the challenges faced in advanced tissue resection. The experts share insights on complications associated with EMR and ESD procedures, emphasizing the need for meticulous technique to ensure patient safety. In the second half of the episode, Dr. Ira Leeds offers a counterpoint, urging caution when managing polyps in the cecum and rectum, while highlighting the role of minimally invasive surgical approaches.

In episode five of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Craig Rosenstengle, a fellow at Baylor University Medical Center in the combined gastroenterology and transplant hepatology pathway. They will discuss hepatic encephalopathy and strategies to prevent readmissions from inadequate transitions of care. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In episode two of our six-part series on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical Center, is joined by Dr. Elliot Tapper, an associate professor in the division of gastroenterology and hepatology at University of Michigan, the director of the Michigan cirrhosis program and the editor in chief of Hepatology Communications. They discuss the changing epidemiology of cirrhosis and hepatic encephalopathy. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC.  

In episode four of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Alpesh Amin, a professor of medicine at the University of California, Irvine ( UCI), the endowed chair of the UCI School of Medicine Department of Medicine, and the executive director of UCI's Hospitalist Program. They discuss missed diagnosis in the inpatient setting. To claim CME for listening, please visit AGA University at agau.gastro.org. This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

Welcome to episode one of our six-part series on hepatic encephalopathy (HE), a major complication and a frequent cause of both initial hospitalization and readmission in cirrhotic patients. In this episode, Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Robert Rahimi, a board-certified physician in transplant hepatology, gastroenterology and internal medicine practicing at Baylor University Medical Center, as well as an associate professor of medicine at Texas A&M. They will discuss current and emerging treatment modalities for HE. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In our final episode on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical, is joined by co-host Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine. They delve into the article "Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy," authored by Drs. Jasmohan S. Bajaj, Angela Gentilly, James Wade, and Michael Godschalk, and published in Clinical Gastroenterology and Hepatology. Together, they explore best practices for staying current with the evolving literature and research on these conditions and discuss strategies for integrating new insights into daily clinical practice. To claim CME for listening, please visit AGA University at agau.gastro.org. This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In episode three of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by co-host Dr. Lisa Byers, an assistant professor within the hospital medicine department at the University of Rochester School of Medicine. They discuss the inadequate practices for HE management in the inpatient setting. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured in both AGA’s Inside Scope podcast channel as well as PIK’s Morning Commute podcast channel. Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Dr. Evan Dellon and Dr. Emily McGowan discuss the features measured by the I-SEE clinical index and its role in evaluating EoE severity, as well as evidence behind the ongoing validation of this tool and implications for future use. Supported by educational grants from Bristol Myers Squibb and Takeda Pharmaceuticals U.S.A., Inc. Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured in both AGA’s Inside Scope podcast channel as well as PIK’s Morning Commute podcast channel. Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Drs. Evan Dellon and Nirmala Gonsalves discuss the roles of different assessment tools in clinical practice, how they traditionally evaluate disease severity, and why the EoE community saw a need for something like the I-SEE Clinical Index. Supported by educational grants from Bristol Myers Squibb and Takeda Pharmaceuticals U.S.A., Inc. Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. Originally released as a bonus episode in June 2023, this episode shares recommendations from the AGA Clinical Practice Update (CPU) on the Endoscopic Approach to Recurrent Acute and Chronic Pancreatitis (published in the October 2022 issue of Gastroenterology). This episode is hosted by Dr. Jana Al Hashash, chair of the AGA Clinical Practice Update Committee and an author of this CPU. She is joined by: Dr. Greg Coté, professor of medicine at Oregon Health Science University. Dr. Daniel Strand, associate professor of interventional endoscopy at University of Virginia. Dr. Ryan Law, doctor of osteopathic medicine at the Mayo Clinic, Rochester. To access the full Clinical Practice Update, visit www.gastro.org/CPU.

Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. This special episode of Inside Scope shares key insights from the AGA Clinical Practice Update on Alpha-Gal Syndrome for the GI Clinician. Originally released as a bonus episode March 2024, this episode shares key insights from the AGA Clinical Practice Update (CPU) on Alpha-Gal Syndrome for the GI Clinician (published in the April 2023 issue of Clinical Gastroenterology and Hepatology). This episode is hosted by Dr. Jana Al Hashash, chair-elect of the AGA Clinical Practice Update Committee and one of the CPU authors. She is joined by her co-authors: -Dr. Sarah McGill, gastroenterologist and associate professor of medicine at the University of North Carolina -Dr. Thomas Platts-Mills, professor of medicine and microbiology and chief at the University of Virginia, a pioneer in discovery of alpha-gal syndrome -Dr. Hannah Dodson, nurse Practitioner affiliated with the University of North Carolina and a patient sharing her perspective on navigating life with alpha-gal syndrome To access the full Clinical Practice Update, visit https://www.gastro.org/CPU

Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. Originally released as a bonus episode in January 2023, this episode shares key insights from the AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease (published in the February 2021 issue of Gastroenterology). This episode is hosted by Dr. Jana Al Hashash, member of the AGA Clinical Practice Update Committee. She is joined by: -Dr. Heather Patton, NAFLD expert and past member of the AGA Clinical Practice Update Committee -Dr. Joseph K. Lim, past chair of the AGA Clinical Practice Update Committee and co-author of this CPU -Dr. Zobair M Younossi, co-author of this CPU To access the full expert review, visit www.gastro.org/CPU.

Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. This episode shares key insights from the AGA Clinical Practice Update: Diet and Nutritional Therapies (published in the March 2024 issue of Gastroenterology). This episode is hosted by Dr. Jana Al Hashash, chair of the AGA Clinical Practice Update Committee. She is joined by authors -Dr. David Binion, professor of medicine and co-director of the IBD Center, director of nutrition support service, at UPMC Presbyterian Hospital and University of Pittsburgh; co-author of CPU -Dr. James Lewis, professor of medicine and epidemiology at the Perelman School of Medicine at the University of Pennsylvania ; co-author of CPU -Ms. Kelly Issokson, registered dietitian and clinical coordinator of digestive diseases at Cedars-Sinai in Los Angeles To access the full Clinical Practice Update, visit www.gastro.org/CPU.

Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. This episode shares key insights from the AGA Clinical Practice Update: Diagnosis and Management of Cyclic Vomiting Syndrome (published in the September 2024 issue of Gastroenterology). We dive into why gastroenterologists and hepatologists should think about a diagnosis of cyclic vomiting syndrome when seeing patients who report recurrent nausea and vomiting symptoms and discuss strategies for therapy. This episode is hosted by Dr. Kyle Staller, CPU author and member of the AGA Clinical Practice Updates Committee. He is joined by fellow authors: -Dr. David Levinthal, assistant professor of medicine at the University of Pittsburgh and director of the UPMC Neurogastroenterology and Motility Center -Dr. Thangam Venkatesan, professor of internal medicine and head of the neurogastroenterology and motility section at The Ohio State University Wexner Medical Center To access the full Clinical Practice Update, visit www.gastro.org/CPU.

Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In episode two, our host Muhamad Nadeem Yousaf, MD, speaks with Nikki Duong, MD, to discuss the nomenclature, pharmacological options, and care recommendations for HRS-AKI patients. Each episode of this series corresponds to a journal article from a September 2023 supplement of Clinical Gastroenterology and Hepatology (CGH), the official clinical practice journal of the American Gastroenterological Association, focusing on addressing knowledge gaps in HRS-AKI. To read the related journal articles and claim CME for listening, visit agau.gastro.org. This series is supported by an independent educational grant from Mallinckrodt

Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In episode three, our host Muhamad Nadeem Yousaf, MD, speaks with Nikhilesh Mazumder, MD, MPH, Shilpa Junna, MD, and Pratima Sharma, MD, MBBS, MS, to discuss initial management of patients with HRS-AKI. They’ll explore topics such as the efficacy of non-selective beta-blockers, the recommended plasma expander for those with decompensated cirrhosis, the roles of renal replacement therapy (RRT), TIPS, and extracorporeal liver support system (ELSS), and the significance of liver transplant in the context of HRS-AKI. Each episode of this series corresponds to a journal article from a September 2023 supplement of Clinical Gastroenterology and Hepatology (CGH), the official clinical practice journal of the American Gastroenterological Association, focusing on addressing knowledge gaps in HRS-AKI. To read the related journal articles and claim CME for listening, visit agau.gastro.org. This series is supported by an independent educational grant from Mallinckrodt

Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In our final episode, our host Muhamad Nadeem Yousaf, MD, speaks with Vivian Ortiz, MD, and Neil Shah, MD, to delve into critical aspects of HRS-AKI. They cover the prognosis after initial management, the significance of reversing renal impairment for liver transplant candidates, the predictive role of MELD score in HRS-AKI, treatment's impact on liver transplant waiting lists, decision-making between liver transplant alone or simultaneous liver-kidney transplant, timing considerations for kidney transplant post-liver transplant, and factors affecting post-transplant prognosis. Each episode of this series corresponds to a journal article from a September 2023 supplement of Clinical Gastroenterology and Hepatology (CGH), the official clinical practice journal of the American Gastroenterological Association, focusing on addressing knowledge gaps in HRS-AKI. To read the related journal articles and claim CME for listening, visit agau.gastro.org. This series is supported by an independent educational grant from Mallinckrodt

Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In episode one, our host Muhamad Nadeem Yousaf, MD, speaks with Danielle Adebayo, MD, and Florence Wong, MD, MBBS, FRCPC, to analyze the pathophysiology of HRS-AKI. They cover peripheral vasodilatation hypothesis shortcomings in HRS-AKI, vasoconstrictor systems, bacterial translocation, inflammation, renal dysfunction, and contributory factors like cholemic nephropathy and adrenal insufficiency, while also suggesting the potential of metabolomic studies for future insights. Each episode of this series corresponds to a journal article from a September 2023 supplement of Clinical Gastroenterology and Hepatology (CGH), the official clinical practice journal of the American Gastroenterological Association, focusing on addressing knowledge gaps in HRS-AKI. To read the related journal articles and claim CME for listening, visit https://agau.gastro.org/cw/course-details?entryId=14556831&subscribed=true. This series is supported by an independent educational grant from Mallinckrodt

Dr. G.S. Raju, editor of the Gastro Grand Rounds section in Gastroenterology, is joined by Drs. Marwan Ghabril and Naga Chalasani to discuss their Gastro Grand Rounds article, "A 68-Year-Old Woman With Unexplained Liver Enzyme Elevation and Active Chronic Hepatitis: Beware of Drug-Induced Autoimmune-Like Hepatitis." https://www.gastrojournal.org/article/S0016-5085(23)05078-3/fulltext Dr. Ghabril is a professor of medicine at Indiana University School of Medicine. Dr. Chalasani is the David W. Crabb professor of gastroenterology and hepatology and an adjunct professor of anatomy, cell biology, and physiology at Indiana University School of Medicine. [0:27] Introduction of the authors and outline of the case. [3:30] Initial thoughts from the authors upon patient presentation. [7:29] After considering additional patient history, what do the authors think about the patient? [10:34] Does the family history of the patient cause the authors to refine the diagnosis? [11:52] Further thoughts from the authors after physical examination of the patient. [14:47] What tests are recommended? [18:55] Additional thoughts from the authors after further testing. [21:06] Should we be testing for hepatitis E? [22:56] Should noninvasive testing be used? [25:11] What is the authors' plan to determine next steps? [27:06] How long should the wait be before a biopsy? [29:08] The patient underwent liver biopsy. How were the results interpreted? [34:31] How long does it take to determine that an appropriate course of action was made? [35:37] How is the patient counselled? [38:43] The LiverTox database. [41:41] Final thoughts from the authors. Thank you for listening. Find this and other articles on our website at https://www.gastrojournal.org. We welcome your feedback. Please email us at gastro@gastro.org. This discussion was recorded on Dec. 20, 2023, and reflects medical knowledge at that time. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent those of the American Gastroenterological Association. The content of this podcast is provided for general information purposes only and does not offer medical or any other type of professional advice.

Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials. In this episode, hosts Drs. Erin Forster and Ayanna Lewis are joined by Drs. Freddy Caldera and Jana Al Hashash, who were part of the inaugural class of participants in AGA’s GI Clinical Trialists Bootcamp program. Today’s discussion focuses on how diversifying participation in clinical trials starts with diversifying our workforce. This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.

Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials. In this episode, co-host Dr. Ayanna Lewis is joined by guest Dr. Erica Cohen, an adult gastroenterologist, IBD specialist and director of the IBD Research Program at Capital Digestive Care in Washington, D.C. Today’s discussion focuses on the community GI’s perspective on clinical trials. This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.

Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials. In this episode, co-host Dr. Erin Forster is joined by guest Kenneth Getz, professor of public health and community medicine and director of the Center for the Study of Drug Development at Tufts University School of Medicine. Ken is also the founder and chairman of the board of directors at CISCRP, a nonprofit dedicated to providing education and information about clinical research. Today's discussion will explore how we can bring awareness of and education on clinical research to the community. This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.

Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials. In this episode, co-host Dr. Erin Forster is joined by guest Dr. Gabriela Radulescu, vice president of medical research and development at Alimentiv, a contract research organization (CRO) specializing in gastroenterology trials. Dr. Radulescu has more than 20 years of experience working in the pharmaceutical industry across multiple functions, including medical affairs, drug safety and pharmacovigilance, clinical research, real world evidence, and patient support programs. At Alimentiv, Dr. Radulescu provides medical leadership for sponsored clinical trials, operational oversight for R&D projects, and medical input to the business development teams. Today’s discussion will explore how CROs are working with investigators and sponsors to increase the diversity of patients enrolling in clinical trials. This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.

Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials. In this episode, hosts Drs. Erin Forster and Ayanna Lewis are joined by Melodie Narain-Blackwell, the founder and president of Color of Crohn’s & Chronic Illness (COCCI). COCCI is a nonprofit dedicated to health equity in BIPOC communities that are challenged with digestive diseases and chronic illnesses. Melodie was diagnosed with Crohn’s disease at the age of 36, thirty years after her symptoms began, and has become a passionate health advocate for people of color who battle chronic illness. Today’s discussion focuses on how we talk about clinical research with patients. This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.

Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials. In this supersized episode, co-host Dr. Ayanna Lewis is joined by guest Dr. Ryan Stidham, an associate professor at the University of Michigan holding appointments in the departments of medicine and computational medicine. Dr. Stidham is a medical data scientist and has a research program that focuses on the development and testing of new technologies for disease assessment and decision making in gastroenterology and general medicine. Today’s discussion will explore how artificial intelligence may help address challenges with participant recruitment for clinical trials, while also discussing the role of AI in the field of gastroenterology more broadly. This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.

Dr. G.S. Raju, editor of the Gastro Grand Rounds section in Gastroenterology, is joined by Dr. David Ballard and Dr. Parakkal Deepak to discuss their Gastro Grand Rounds article, "Long-Standing Symptomatic Fistulizing Perianal Crohn’s Disease: Progression Beyond Inflammation." https://www.gastrojournal.org/article/S0016-5085(23)04997-1/fulltext Dr. Ballard is an assistant professor of radiology and director of the 3D Printing Lab at the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis. Dr. Deepak is an Associate Professor of Medicine in the Division of Gastroenterology at Washington University School of Medicine in St. Louis. [0:27] Introduction of the authors and outline of the case. [2:29] What initial steps does a gastroenterologist take to manage a patient who presents with possible perianal Crohn’s disease? [6:47] How does an imaging specialist plan for imaging of the perianal disease, and what techniques are used in support of the endoscopist or gastroenterologist? [11:33] The role of point-of-care ultrasound in perianal disease. [15:38] When is a colorectal surgeon brought on board, and what does a colorectal surgeon do when examining the patient? [19:57] How does the clinician manage abscess and fistula? [25:13] Are there any radiological signs that indicate that a particular fistula may be particularly difficult to manage? [29:38] What is a standard treatment for perianal fistula that evolves to cancer? [31:27] Did the patient notice a change in the nature of the discharge? [32:35] Final thoughts from the authors. Thank you for listening. Find this and other articles on our website at https://www.gastrojournal.org. We welcome your feedback. Please email us at gastro@gastro.org. This discussion was recorded on Nov. 1, 2023, and reflects medical knowledge at that time. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent those of the American Gastroenterological Association. The content of this podcast is provided for general information purposes only and does not offer medical or any other type of professional advice.

Welcome to the first in a series of new podcast episodes from the pages of Gastroenterology, the flagship journal of the American Gastroenterological Association and the most prominent journal in the field of gastrointestinal disease. This podcast series covers articles in the journal’s “Gastro Grand Rounds” section, which features discussions among multidisciplinary teams of experts on the management of complex clinical cases. Gastro Grand Rounds: Managing Diverticulitis Dr. G.S. Raju, editor of the Gastro Grand Rounds section in Gastroenterology, is joined by Dr. Lisa Strate to discuss her article, “Recurrent Lower Abdominal Pain, Altered Bowel Habits, and Malaise: Conservative or Surgical Approach to a Common Disorder.” https://www.gastrojournal.org/article/S0016-5085(23)00042-2/fulltext Dr. Strate is a professor of medicine at the University of Washington School of Medicine and is the section head of gastroenterology at Harborview Medical Center. Dr. Strate’s research has examined risk factors for the development of diverticular disease. Her work has informed the development of guidelines, dietary recommendations, and measurements for the prevention of diverticulitis. She has investigated the role of chronic inflammation and the gut microbiome in diverticulitis. She is a fellow of AGA. [0:27] Introduction of the author. [2:20] The utility of CT in evaluating diverticulitis. [5:49] Managing a patient with uncomplicated diverticulitis. [11:00] Take-home instructions for the patient. [14:12] Preparing the patient colonoscopy, strategies used during the procedure, and documenting findings. [19:11] Utility of a barium enema. [20:22] The patient returns and has left lower quadrant pain. What are the next steps? [24:30] Laying out the pros and cons of continued medical management compared with surgery for a patient who has recurrent episodes of uncomplicated diverticulitis. [28:00] Does the author’s institution have a support group for patients? [28:55] What is the longest period of antibiotics the author has given to a patient who does not want surgery? [30:34] Take-home messages for fellows and residents. Thank you for listening. Find this and other articles on our website at https://www.gastrojournal.org. We welcome your feedback. Please email us at gastro@gastro.org. This discussion was recorded on Sept. 5, 2023, and reflects medical knowledge at that time. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent those of the American Gastroenterological Association. The content of this podcast is provided for general information purposes only and does not offer medical or any other type of professional advice.

Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guest Dr. Jessica Allegretti to discuss FMT and new microbiome therapies. You can now claim CME for listening – visit agau.gastro.org. This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.

Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guests Dr. Kevin Garey and a patient to discuss the impact of recurrent CDI on patients and their lives. This episode does not offer Continuing Medical Education (CME) credits. This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.

Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guests Rebecca Perez and Cheri Lattimer to discuss case management and transitions of care in C. difficile infection. You can now claim CME for listening – visit agau.gastro.org. This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.

Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guest Dr. Colleen Kelly to discuss how to reconcile guideline differences for testing and treatment of C. difficile. You can now claim CME for listening – visit agau.gastro.org. This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.

Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna describe the shifts in the microbiota with C. difficile infection. This episode was originally released as a bonus episode in November 2022. You can now claim CME for listening – visit agau.gastro.org. This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.

Welcome to our new six-part series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this episode, Drs. Paul Feuerstadt and Sahil Khanna cover risk factors for initial and recurrent C. difficile infection. This episode was originally released as a bonus episode in November 2022. You can now claim CME for listening – visit agau.gastro.org. This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.

Welcome to the final episode of our series Innovation in Duodenoscope Design. Guest host Nina Nandy, MD, is joined by Michael L. Kochman, MD, AGAF, to discuss the recently published multisociety guideline on reprocessing flexible GI endoscopes and if the recommendations put forth are sufficient to address the current challenges posed by duodenoscope-related infections. This series is supported by an unrestricted educational grant from Boston Scientific. To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.

Episode 2 of our new series Innovation in Duodenoscope Design is all about disposable scopes! Join host Adarsh Thaker, MD, and his guests Gregory A. Cote, MD, and Andrew Ross, MD, as they cover: • How to determine whether a scope is clean or not and how to know it is ready for the next patient. • Cost and reimbursement factors into declaring that the risk of exogenous is "low". • If single use duodenoscopes make sense not only in infection prevention but also in the cost to the environment. This series is supported by an unrestricted educational grant from Boston Scientific. To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.

Welcome to our new series Innovation in Duodenoscope Design! Episode one is hosted by Adarsh Thaker, MD. He is joined by Shani Haugen, PhD, who will help us understand how the FDA is addressing duodenoscope-related infection issues. They’ll answer key questions like what do FDA’s Safety Communications mean for GIs, what have we learned from 522 studies, and what do we still have to learn? This series is supported by an unrestricted educational grant from Boston Scientific. To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.

Uzma Siddiqui, MD, is here to host episode 3 of our series Innovation in Duodenoscope Design! She’s joined by Amrita Sethi, MD, to discuss opportunities with single-use scopes beyond infection control, with a focus on ergonomic design. They’ll talk through how disposable scopes impact workflow both on and off the unit. Continue listening for a discussion on advantages and disadvantages of the widespread use of disposable scopes now and in the future. This series is supported by an unrestricted educational grant from Boston Scientific. To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.

Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion. In episode 3 of 4, we're joined by guests Shuba Bhat, PharmD, and Jennifer Seminerio-Diehl, MD, to discuss: • What are the practical logistics when you work on a switch with a patient? • How do you address a situation where a patient says they are experiencing an increase in symptoms after a switch? • Are there any situations where you would consider appealing an insurance decision and not switching? • What tests do you use to determine whether a patient is experiencing active disease before or after a switch? This series is supported by independent medical education grants from Amgen and Pfizer. To collect CME credit for listening, visit agau.gastro.org.

Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion. In episode 4 of 4, we're joined by guests Shuba Bhat, PharmD, and Miguel Regueiro, MD, to discuss: • Their approach to shared decision-making with a patient that’s concerned about a switch. And how often does this occur? • Do you suggest that the patient speak with multiple team members? • As a clinical pharmacist how do you counsel these patients? • What is the general approach to switching used at Cleveland Clinic and what do you find has been most helpful? This series is supported by independent medical education grants from Amgen and Pfizer. To collect CME credit for listening, visit agau.gastro.org.

Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion. In episode 2 of 4, we’ll discuss: • How do you prepare your team and the patient for a switch to a biosimilar? • Are there any situations where switching is not appropriate? • What do you think about multiple switches? • How do you minimize the potential for a nocebo effect? This series is supported by independent medical education grants from Amgen and Pfizer. To collect CME credit for listening, visit agau.gastro.org.

Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion. In episode 1 of 4, we’ll discuss: • How do you explain biosimilars to a patient with moderate-to-severe Crohn’s disease when you start them on a biologic? • What are some of the common questions that patients ask and how do you address them? • Do you set goals of therapy with your patients and what are they? This series is supported by independent medical education grants from Amgen and Pfizer. To collect CME credit for listening, visit agau.gastro.org.